High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products
Author(s): Quamrun Masuda, Mamoon Rashid, Nasheed Shams, Mullins Randy
Issue: Nov/Dec 2014 - Volume 18, Number 6
View All Articles in Issue
Page(s): 520-525
Download in electronic PDF format for $75
Abstract: The compounding and evaluation of ondansetron hydrochloride dihydrate topical gel, 2.5% w/w, were conducted in this study. The gelling agent was Carbopol 940. Ethanol 70% in purified water was used to dissolve the drug and disperse the gelling agent. A gel was formed by adding drops of 0.1 N sodium hydroxide solution. To assay this gel, we developed a simple and reproducible stabilityindicating high-performance liquid chromatographic method. This method was validated for specificity, accuracy, and precision. The compounded gel was assayed in triplicate, and the average recovery was 98.3%. Ondansetron marketed products were analyzed for comparison with the compounded formulation. Assay, accuracy, and precision data of the compounded topical gel were comparable to the marketed products.
Related Keywords:
ondansetron hydrochloride dihydrate, topical preparations, Carbopol 940, antiemetic, nausea, vomiting, serotonin 5-HT3 receptor antagonist, 5-HT3 blocker, formulations, HPLC assay development
Related Categories:
CANCER AND AIDS, EXCIPIENTS, PEER-REVIEWED, QUALITY CONTROL, DOSAGE FORMS/DRUG CARRIERS
Printer-Friendly Version
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products
Quamrun Masuda, Mamoon Rashid, Nasheed Shams, Mullins Randy
|
Nov/Dec 2014
Pg. 520-525
|
Quality-Control Analytical Methods: High-Performance Liquid Chromatography
Kupiec Thomas C
|
May/Jun 2004
Pg. 223-227
|
Ondansetron Hydrochloride 2-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 339
|
Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs
Gorman Gregory, Sokom Simara, Coward Lori, Arnold John J
|
Mar/Apr 2017
Pg. 164-170
|
Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 60
|
Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
|
Jul/Aug 2004
Pg. 269-274
|
A New High-Performance Liquid Chromatographic Method for Fludarabine and Fludarabine Phosphate Compounded in Liposomes
Abang Anthony M, Abbas S Ali, Pham Trinh, Lambros Maria Polikandritou
|
Jul/Aug 2001
Pg. 320-322
|
Nausea and Vomiting in Hospice Patients
Boomsma Diane
|
Jul/Aug 2000
Pg. 250-251
|
Ondansetron Hydrochloride 0.8mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2007
Pg. 158
|
ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient
Moon Richard B
|
Mar/Apr 2006
Pg. 95-98
|
Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel
Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott
|
May/Jun 2013
Pg. 247-253
|
Quantitation of Testosterone-Cypionate-in-Oil Injection using High Performance Liquid Chromatography
Gupta Vishnu D, Pramar Y
|
Jul/Aug 1999
Pg. 314-315
|
Quantitation of Testosterone Propionate in an Injection Using High Performance Liquid Chromatography
Gupta Vishnu D
|
Mar/Apr 1999
Pg. 158-159
|
Novel Approaches to Topical Psoriasis Therapy
Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
|
Sep/Oct 2015
Pg. 357-365
|
Ondansetron Suppositories: Extemporaneous Preparation, Drug Release, Stability and Flux through Rabbit Rectal Membrane
Tenjarla Srini N, Ward Earl S, Fox Janet L
|
Jan/Feb 1998
Pg. 83-88
|
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride
Alexander Kenneth S, Thyangarajapuram N
|
Sep/Oct 2003
Pg. 389-393
|
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration
Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A
|
Mar/Apr 2008
Pg. 170-173
|
Validation of Ultraviolet-visible and High-performance Liquid Chromatographic Methods for the Determination of Sodium p-Aminosalicylate and m-Aminophenol in a New Pharmaceutical Formulation
Hergert Lisandro Y, Ravetti Soledad, Mazzieri Maria R
|
Jan/Feb 2016
Pg. 63-70
|
Granisetron 1-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 66
|
Physical and Chemical Stability of Palonosetron Hydrochloride with Topotecan Hydrochloride and Irinotecan Hydrochloride during Simulated Y-Site Administration
Trissel Lawrence A, Xu Quanyun A
|
May/Jun 2005
Pg. 238-241
|
| Return to Top |
